IPO News Archive

AutoGenomics pulls $60 million IPO

2/15/13


AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its IPO on Friday, according to an underwriter. The Vista, CA-based company was founded in 1999 and booked $17 million in sales for the 12 months ended 9/30/2012. Leerink Swann was set to be the sole bookrunner on the deal.
Keywords/Tickers: AGMX
Source: www.RenaissanceCapital.com
blog comments powered by Disqus
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the Global IPO Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in Global IPO Fund
About Fund Prospectus Invest